RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+2.27%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$822M
AUM Growth
+$822M
(-1.8%)
Cap. Flow
+$5.83M
Cap. Flow
% of AUM
0.71%
Top 10 Holdings %
Top 10 Hldgs %
40.53%
Holding
68
New
13
Increased
13
Reduced
19
Closed
21
Top Buys
| 1 |
Medtronic
MDT
|
$37.6M |
| 2 |
Universal Health Services
UHS
|
$35.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$29.1M |
| 4 |
AGN
ALLERGAN INC
AGN
|
$28.5M |
| 5 |
Zimmer Biomet
ZBH
|
$26.6M |
Top Sells
| 1 |
Tenet Healthcare
THC
|
$33.8M |
| 2 |
Agilent Technologies
A
|
$24.5M |
| 3 |
Bristol-Myers Squibb
BMY
|
$21.7M |
| 4 |
Insulet
PODD
|
$21.7M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$19.8M |
Sector Composition
| 1 | Healthcare | 77.94% |
| 2 | Technology | 2% |
| 3 | Communication Services | 1.83% |
| 4 | Industrials | 1.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSLT
26
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $16.5M | 2% | 1,164,257 -20,090 | -2% | -$284K |
|
27
Accuray
ARAY
$157M
| $16.4M | 1.99% | 1,866,260 +390,900 | +26% | +$3.44M |
|
|
OXFD
28
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $16.2M | 1.96% | 960,820 +335,951 | +54% | +$5.65M |
|
|
CSII
29
DELISTED
Cardiovascular Systems, Inc.
CSII
| $15.4M | 1.86% | 493,345 +101,718 | +26% | +$3.17M |
|
|
MODN
30
DELISTED
MODEL N, INC.
MODN
| $15M | 1.82% | 1,360,878 +506,500 | +59% | +$5.6M |
|
|
HMSY
31
DELISTED
HMS Holdings Corp.
HMSY
| $11.5M | 1.4% | +565,593 | New | +$11.5M |
|
32
Standard BioTools
LAB
$481M
| $11.5M | 1.4% | +392,540 | New | +$11.5M |
|
33
Orthofix Medical
OFIX
$592M
| $10.2M | 1.23% | +280,642 | New | +$10.2M |
|
34
Inogen
INGN
$216M
| $10.2M | 1.23% | 450,500 -10,423 | -2% | -$235K |
|
35
Align Technology
ALGN
$10.3B
| $9.83M | 1.19% | 175,452 -119,160 | -40% | -$6.68M |
|
|
AKAO
36
DELISTED
Achaogen, Inc.
AKAO
| $9.06M | 1.1% | 648,879 -4,821 | -0.7% | -$67.3K |
|
37
Prothena Corp
PRTA
$441M
| $8.36M | 1.01% | 370,520 -189,091 | -34% | -$4.26M |
|
|
DSCI
38
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $6.94M | 0.84% | 600,677 +2,600 | +0.4% | +$30.1K |
|
|
FLXN
39
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $6.8M | 0.82% | 504,083 +10,900 | +2% | +$147K |
|
40
Geron
GERN
$893M
| $6.59M | 0.8% | 2,051,312 -66,243 | -3% | -$213K |
|
|
RXDX
41
DELISTED
Ignyta, Inc.
RXDX
| $5.25M | 0.64% | 577,653 -22,347 | -4% | -$203K |
|
42
VanEck Pharmaceutical ETF
PPH
$621M
| $403K | 0.05% | 6,500 | – | – |
|
43
iShares Biotechnology ETF
IBB
$5.6B
| $308K | 0.04% | +1,200 | New | +$308K |
|
|
ICPT
44
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $251K | 0.03% | 1,062 -50,051 | -98% | -$11.8M |
|
45
Boston Scientific
BSX
$156B
| $128K | 0.02% | +10,000 | New | +$128K |
|
|
VIRX
46
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $65K | 0.01% | 10,000 | – | – |
|
47
Tenax Therapeutics
TENX
$27.3M
| $51K | 0.01% | +12,500 | New | +$51K |
|
48
VanEck Biotech ETF
BBH
$350M
| – | – | -3,208 | Closed | -$292K |
|
|
49
Bristol-Myers Squibb
BMY
$96B
| – | – | -418,500 | Closed | -$21.7M |
|
50
Cerus
CERS
$251M
| – | – | -586,205 | Closed | -$2.81M |
|